FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

836531000168100: poliovirus serotype 2 inactivated antigen (AU substance)

Status: current, Primitive. Date: 31-Oct 2016. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
1698321000168112 poliovirus serotype 2 inactivated antigen (AU substance) en Fully specified name Active Case sensitive Australian Medicines Terminology module
1698331000168110 poliovirus type 2 inactivated antigen en Synonym Active Case sensitive Australian Medicines Terminology module
1698491000168117 poliovirus serotype 2 inactivated antigen en Synonym Active Case sensitive Australian Medicines Terminology module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
poliovirus type 2 inactivated antigen Is a medicinal substance true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
diphtheria + tetanus + pertussis 5 component + hepatitis B + polio trivalent + Haemophilus influenzae type b conjugate (PRP-OMP) vaccine has intended active ingredient True poliovirus type 2 inactivated antigen Inferred relationship Some 599040648
diphtheria + tetanus + pertussis 5 component + hepatitis B + polio trivalent + Haemophilus influenzae type b conjugate (PRP-OMP) vaccine, 0.5 mL vial has intended active ingredient True poliovirus type 2 inactivated antigen Inferred relationship Some 555176489
diphtheria + tetanus + pertussis 5 component + hepatitis B + polio trivalent + Haemophilus influenzae type b conjugate (PRP-OMP) vaccine, 0.5 mL vial has Australian BoSS True poliovirus type 2 inactivated antigen Inferred relationship Some 555176489
Vaxelis injection, 0.5 mL vial has intended active ingredient True poliovirus type 2 inactivated antigen Inferred relationship Some 1257894935
Vaxelis injection, 0.5 mL vial has Australian BoSS True poliovirus type 2 inactivated antigen Inferred relationship Some 1257894935
Vaxelis injection, 0.5 mL syringe has intended active ingredient True poliovirus type 2 inactivated antigen Inferred relationship Some 1611695191
Vaxelis injection, 0.5 mL syringe has Australian BoSS True poliovirus type 2 inactivated antigen Inferred relationship Some 1611695191
diphtheria + tetanus + pertussis 5 component + hepatitis B + polio trivalent + Haemophilus influenzae type b conjugate (PRP-OMP) vaccine, 0.5 mL syringe has intended active ingredient True poliovirus type 2 inactivated antigen Inferred relationship Some 680195223
diphtheria + tetanus + pertussis 5 component + hepatitis B + polio trivalent + Haemophilus influenzae type b conjugate (PRP-OMP) vaccine, 0.5 mL syringe has Australian BoSS True poliovirus type 2 inactivated antigen Inferred relationship Some 680195223
diphtheria + tetanus + pertussis + hepatitis B + polio trivalent vaccine has intended active ingredient True poliovirus type 2 inactivated antigen Inferred relationship Some 2
diphtheria + tetanus + pertussis + hepatitis B + polio trivalent vaccine injection, 0.5 mL syringe has Australian BoSS True poliovirus type 2 inactivated antigen Inferred relationship Some 231892134
diphtheria + tetanus + pertussis + hepatitis B + polio trivalent vaccine injection, 0.5 mL syringe has intended active ingredient True poliovirus type 2 inactivated antigen Inferred relationship Some 231892134
Infanrix Penta injection, 0.5 mL syringe has intended active ingredient True poliovirus type 2 inactivated antigen Inferred relationship Some 1258734278
Infanrix Penta injection, 0.5 mL syringe has Australian BoSS True poliovirus type 2 inactivated antigen Inferred relationship Some 1258734278
diphtheria + tetanus + pertussis 5 component + polio trivalent vaccine has intended active ingredient True poliovirus type 2 inactivated antigen Inferred relationship Some 6
diphtheria + tetanus + pertussis 5 component + polio trivalent adolescent/adult vaccine injection, 0.5 mL syringe has intended active ingredient True poliovirus type 2 inactivated antigen Inferred relationship Some 886450362
diphtheria + tetanus + pertussis 5 component + polio trivalent adolescent/adult vaccine injection, 0.5 mL syringe has Australian BoSS True poliovirus type 2 inactivated antigen Inferred relationship Some 886450362
Adacel Polio injection, 0.5 mL syringe has Australian BoSS True poliovirus type 2 inactivated antigen Inferred relationship Some 115388646
Adacel Polio injection, 0.5 mL syringe has intended active ingredient True poliovirus type 2 inactivated antigen Inferred relationship Some 115388646
Adacel Polio injection, 0.5 mL vial has Australian BoSS True poliovirus type 2 inactivated antigen Inferred relationship Some 460910010
Adacel Polio injection, 0.5 mL vial has intended active ingredient True poliovirus type 2 inactivated antigen Inferred relationship Some 460910010
diphtheria + tetanus + pertussis 5 component + polio trivalent adolescent/adult vaccine injection, 0.5 mL vial has Australian BoSS True poliovirus type 2 inactivated antigen Inferred relationship Some 2013261702
diphtheria + tetanus + pertussis 5 component + polio trivalent adolescent/adult vaccine injection, 0.5 mL vial has intended active ingredient True poliovirus type 2 inactivated antigen Inferred relationship Some 2013261702
polio trivalent inactivated vaccine has intended active ingredient True poliovirus type 2 inactivated antigen Inferred relationship Some 2
polio trivalent inactivated vaccine injection, 0.5 mL syringe has intended active ingredient True poliovirus type 2 inactivated antigen Inferred relationship Some 1368285370
polio trivalent inactivated vaccine injection, 0.5 mL syringe has Australian BoSS True poliovirus type 2 inactivated antigen Inferred relationship Some 1368285370
Ipol injection, 0.5 mL syringe has intended active ingredient True poliovirus type 2 inactivated antigen Inferred relationship Some 863019322
Ipol injection, 0.5 mL syringe has Australian BoSS True poliovirus type 2 inactivated antigen Inferred relationship Some 863019322
diphtheria + tetanus + pertussis 3 component + polio trivalent vaccine has intended active ingredient True poliovirus type 2 inactivated antigen Inferred relationship Some 5
Quadracel (Bordetella pertussis filamentous haemagglutinin antigen 20 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 20 microgram + diphtheria toxoid 30 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 40 international units) injection, 0.5 mL vial (trade product unit of use) has Australian BoSS True poliovirus type 2 inactivated antigen Inferred relationship Some 1360771558
Quadracel (Bordetella pertussis filamentous haemagglutinin antigen 20 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 20 microgram + diphtheria toxoid 30 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 40 international units) injection, 0.5 mL vial (trade product unit of use) has intended active ingredient True poliovirus type 2 inactivated antigen Inferred relationship Some 1360771558
diphtheria + tetanus + pertussis 3 component + polio trivalent child vaccine injection, 0.5 mL syringe has Australian BoSS True poliovirus type 2 inactivated antigen Inferred relationship Some 1811315046
diphtheria + tetanus + pertussis 3 component + polio trivalent child vaccine injection, 0.5 mL syringe has intended active ingredient True poliovirus type 2 inactivated antigen Inferred relationship Some 1811315046
Boostrix-IPV injection, 0.5 mL syringe has Australian BoSS True poliovirus type 2 inactivated antigen Inferred relationship Some 584207098
Boostrix-IPV injection, 0.5 mL syringe has intended active ingredient True poliovirus type 2 inactivated antigen Inferred relationship Some 584207098
Infanrix-IPV injection, 0.5 mL syringe has Australian BoSS True poliovirus type 2 inactivated antigen Inferred relationship Some 1978386202
Infanrix-IPV injection, 0.5 mL syringe has intended active ingredient True poliovirus type 2 inactivated antigen Inferred relationship Some 1978386202
diphtheria + tetanus + pertussis 3 component + polio trivalent adolescent/adult vaccine injection, 0.5 mL syringe has Australian BoSS True poliovirus type 2 inactivated antigen Inferred relationship Some 226056390
diphtheria + tetanus + pertussis 3 component + polio trivalent adolescent/adult vaccine injection, 0.5 mL syringe has intended active ingredient True poliovirus type 2 inactivated antigen Inferred relationship Some 226056390
diphtheria + tetanus + pertussis 5 component + polio trivalent child vaccine injection, 0.5 mL vial has Australian BoSS True poliovirus type 2 inactivated antigen Inferred relationship Some 2123932250
diphtheria + tetanus + pertussis 5 component + polio trivalent child vaccine injection, 0.5 mL vial has intended active ingredient True poliovirus type 2 inactivated antigen Inferred relationship Some 2123932250
Infanrix Hexa injection, 0.5 mL syringe has Australian BoSS True poliovirus type 2 inactivated antigen Inferred relationship Some 2075498074
Infanrix Hexa injection, 0.5 mL syringe has intended active ingredient True poliovirus type 2 inactivated antigen Inferred relationship Some 2075498074
diphtheria + tetanus + pertussis + hepatitis B + polio trivalent + Haemophilus influenzae type b conjugate (PRP-T) vaccine has intended active ingredient True poliovirus type 2 inactivated antigen Inferred relationship Some 3
diphtheria + tetanus + pertussis + hepatitis B + polio trivalent + Haemophilus influenzae type b conjugate (PRP-T) vaccine injection, 0.5 mL syringe has Australian BoSS True poliovirus type 2 inactivated antigen Inferred relationship Some 568210914
diphtheria + tetanus + pertussis + hepatitis B + polio trivalent + Haemophilus influenzae type b conjugate (PRP-T) vaccine injection, 0.5 mL syringe has intended active ingredient True poliovirus type 2 inactivated antigen Inferred relationship Some 568210914
Hexaxim injection, 0.5 mL syringe has Australian BoSS True poliovirus type 2 inactivated antigen Inferred relationship Some 424521064
Hexaxim injection, 0.5 mL syringe has intended active ingredient True poliovirus type 2 inactivated antigen Inferred relationship Some 424521064

Reference Sets

Unit of use size reference set

Back to Start